Alkem Laboratories Business Update
Alkem Laboratories announced the US FDA classified its Amaliya, Daman facility as 'Official Action Indicated'. Operations continue at the site.
ALFA Filings
Every announcement, straight from the exchange
Every Alkem Laboratories business update announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Alkem Laboratories announced the US FDA classified its Amaliya, Daman facility as 'Official Action Indicated'. Operations continue at the site.
Alkem Laboratories Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended 31st March, 2026.
Alkem Laboratories' Taloja CRO facility successfully cleared an unannounced US FDA inspection. No Form 483 observations were issued, confirming compliance with international regulatory standards.
Alkem Laboratories Limited's manufacturing facility in Amaliya, Daman, underwent a US FDA inspection from April 20 to May 1, 2026. The company received Form 483 with seven observations and intends to address them within the stipulated timeframe. This is a routine regulatory update regarding facility compliance.